FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309922067> ?p ?o ?g. }

• W4309922067 endingPage "175428" @default.
• W4309922067 startingPage "175428" @default.
• W4309922067 abstract "Hepatic cholestasis can develop into liver fibrosis and eventually liver failure. Currently, ursodeoxycholic acid (UDCA) or UDCA combined with fenofibrate is used for cholestasis treatment. Rosiglitazone inhibited α-naphthyl isothiocyanate (ANIT)-induced cholestasis in mice. In this study, we compared the effect of rosiglitazone, UDCA, fenofibrate, combined rosiglitazone and fenofibrate or UDCA and fenofibrate on ANIT-induced cholestasis. C57BL/6J mice were induced cholestasis by ANIT while treated with rosiglitazone, UDCA, fenofibrate, combination of rosiglitazone and fenofibrate, or combination of UDCA and fenofibrate. Liver and serum samples were collected to determine liver necrosis and serum biochemical parameters. Rosiglitazone alone or combined with fenofibrate demonstrated better effects than UDCA alone or UDCA combined with fenofibrate in reduction of cholestasis-induced serum biochemical parameters and liver necrosis. Surprisingly, UDCA combined with fenofibrate, but not rosiglitazone combined with fenofibrate, potently increased accumulation of free fatty acids (FFAs) in the liver. Mechanistically, the protection of combination of rosiglitazone and fenofibrate against cholestasis was attributed to activated adiponectin pathway to enhance FXR and mitochondrial functions and reduce apoptosis in the liver. The accumulation of FFAs in the liver by combination of UDCA and fenofibrate was caused by activation of fatty acid biosynthesis and uptake, and triglyceride hydrolysis. Taken together, our study not only demonstrates the adverse effect of combination therapy of UDCA and fenofibrate, but also suggests the combination of rosiglitazone and fenofibrate can be another option for cholestasis treatment." @default.
• W4309922067 created "2022-11-30" @default.
• W4309922067 creator A5002744113 @default.
• W4309922067 creator A5005205790 @default.
• W4309922067 creator A5007205089 @default.
• W4309922067 creator A5028875731 @default.
• W4309922067 creator A5060454242 @default.
• W4309922067 creator A5074266536 @default.
• W4309922067 creator A5084926415 @default.
• W4309922067 date "2023-01-01" @default.
• W4309922067 modified "2023-09-26" @default.
• W4309922067 title "A novel therapy for hepatic cholestasis treatment—the combination of rosiglitazone and fenofibrate" @default.
• W4309922067 cites W1556584205 @default.
• W4309922067 cites W1966052494 @default.
• W4309922067 cites W1980371754 @default.
• W4309922067 cites W1986666681 @default.
• W4309922067 cites W1993132387 @default.
• W4309922067 cites W1994191061 @default.
• W4309922067 cites W1996907401 @default.
• W4309922067 cites W2006516019 @default.
• W4309922067 cites W2022184946 @default.
• W4309922067 cites W2022419155 @default.
• W4309922067 cites W2022473709 @default.
• W4309922067 cites W2024656201 @default.
• W4309922067 cites W2033296706 @default.
• W4309922067 cites W2036639220 @default.
• W4309922067 cites W2060252228 @default.
• W4309922067 cites W2079635516 @default.
• W4309922067 cites W2094212146 @default.
• W4309922067 cites W2110414129 @default.
• W4309922067 cites W2113816659 @default.
• W4309922067 cites W2125457175 @default.
• W4309922067 cites W2134857656 @default.
• W4309922067 cites W2138139209 @default.
• W4309922067 cites W2147921766 @default.
• W4309922067 cites W2151764038 @default.
• W4309922067 cites W2162808237 @default.
• W4309922067 cites W2518389324 @default.
• W4309922067 cites W2565693018 @default.
• W4309922067 cites W2730062641 @default.
• W4309922067 cites W2922727372 @default.
• W4309922067 cites W2941687336 @default.
• W4309922067 cites W2978327561 @default.
• W4309922067 cites W2982388833 @default.
• W4309922067 cites W3087505454 @default.
• W4309922067 cites W3135550722 @default.
• W4309922067 cites W3149930516 @default.
• W4309922067 cites W3152920690 @default.
• W4309922067 cites W3196850442 @default.
• W4309922067 cites W4293201222 @default.
• W4309922067 cites W4296816736 @default.
• W4309922067 doi "https://doi.org/10.1016/j.ejphar.2022.175428" @default.
• W4309922067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36436592" @default.
• W4309922067 hasPublicationYear "2023" @default.
• W4309922067 type Work @default.
• W4309922067 citedByCount "0" @default.
• W4309922067 crossrefType "journal-article" @default.
• W4309922067 hasAuthorship W4309922067A5002744113 @default.
• W4309922067 hasAuthorship W4309922067A5005205790 @default.
• W4309922067 hasAuthorship W4309922067A5007205089 @default.
• W4309922067 hasAuthorship W4309922067A5028875731 @default.
• W4309922067 hasAuthorship W4309922067A5060454242 @default.
• W4309922067 hasAuthorship W4309922067A5074266536 @default.
• W4309922067 hasAuthorship W4309922067A5084926415 @default.
• W4309922067 hasConcept C126322002 @default.
• W4309922067 hasConcept C134018914 @default.
• W4309922067 hasConcept C170493617 @default.
• W4309922067 hasConcept C185592680 @default.
• W4309922067 hasConcept C2778110834 @default.
• W4309922067 hasConcept C2778593092 @default.
• W4309922067 hasConcept C2780152017 @default.
• W4309922067 hasConcept C2780965833 @default.
• W4309922067 hasConcept C71924100 @default.
• W4309922067 hasConcept C98274493 @default.
• W4309922067 hasConceptScore W4309922067C126322002 @default.
• W4309922067 hasConceptScore W4309922067C134018914 @default.
• W4309922067 hasConceptScore W4309922067C170493617 @default.
• W4309922067 hasConceptScore W4309922067C185592680 @default.
• W4309922067 hasConceptScore W4309922067C2778110834 @default.
• W4309922067 hasConceptScore W4309922067C2778593092 @default.
• W4309922067 hasConceptScore W4309922067C2780152017 @default.
• W4309922067 hasConceptScore W4309922067C2780965833 @default.
• W4309922067 hasConceptScore W4309922067C71924100 @default.
• W4309922067 hasConceptScore W4309922067C98274493 @default.
• W4309922067 hasFunder F4320321001 @default.
• W4309922067 hasFunder F4320328099 @default.
• W4309922067 hasFunder F4320328119 @default.
• W4309922067 hasFunder F4320335787 @default.
• W4309922067 hasLocation W43099220671 @default.
• W4309922067 hasLocation W43099220672 @default.
• W4309922067 hasOpenAccess W4309922067 @default.
• W4309922067 hasPrimaryLocation W43099220671 @default.
• W4309922067 hasRelatedWork W1973056587 @default.
• W4309922067 hasRelatedWork W2073361868 @default.
• W4309922067 hasRelatedWork W2126085844 @default.
• W4309922067 hasRelatedWork W2165052328 @default.
• W4309922067 hasRelatedWork W2373128075 @default.
• W4309922067 hasRelatedWork W2508323870 @default.

• next